Log In
Print this Print this

ViraferonPeg, peginterferon alfa-2b

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionPeginterferon alfa-2b
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C virus (HCV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today